International Journal of Drug Delivery Technology
Volume 16, Issue 3s, 2026

Guidelines for Early Screening of Breast Cancer in India: A Systematic Review

Dr. Kuljinder Kaur 1, Dr. Ashish Baldi 2

1Assistant Professor, Dev Samaj College of Education for Women, Ferozepur, Punjab, India.
Email: dhillongaggu@ymail.com

2Professor, Department of Pharmaceutical Sciences and Technology, Maharaja Ranjit Singh Punjab Technical University, Bathinda, Punjab, India.
Email: baldiashish@gmail.com


ABSTRACT

Breast Cancer is becoming the predominant cause affecting the life expectancy of women in India. The incidence rate and mortality rate from the disease are continuously rising in the country. High-income countries, despite a high incidence rate, could successfully achieve the mortality reduction by adopting organised screening programs. Against this backdrop, there is an urgent need for coherent, evidence-based early screening guidelines tailored to India's epidemiologic profile, resource constraints, and sociocultural context. This paper synthesizes national and international evidence on screening modalities (CBE, BSE, mammography, and emerging technologies), programmatic experiences, and cost effectiveness to propose pragmatic breast cancer early screening guidelines for India. The objectives are to define context-appropriate target age groups, screening intervals, and to outline health-system and community strategies to enhance the uptake, equity, and sustainability of early detection efforts nationwide.

Keywords: Breast Cancer, Screening Age, Screening Interval, screening strategy, National and International Research Agencies.

How to cite this article: Kaur K, Baldi A. Guidelines for early screening of breast cancer in India: a systematic review. Int J Drug Deliv Technol. 2026;16(3s): 666-673; DOI: 10.25258/ijddt.16.3s.85

Source of support: Nil.

Conflict of interest: None